戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              MnSOD contains a nutrient- and ionizing radiation (IR)-d
2                                              MnSOD enzyme activity and its mRNA were decreased signif
3                                              MnSOD expression was significantly (P<0.05) decreased in
4                                              MnSOD lines had a three-fold increase in MnSOD activity,
5                                              MnSOD overexpression prevented a glucose-induced increas
6                                              MnSOD protects the retina from diabetes-induced abnormal
7                                              MnSOD protein carrying a K89A mutation had significantly
8                                              MnSOD siRNA also reduced nitric oxide production in supe
9                                              MnSOD-promoter/enhancer analysis demonstrates that p53 i
10 pression of cytoprotective molecules (Bcl-2, MnSOD, GADD45beta, A1) and suppressing proinflammatory t
11 verexpression of p38K extends life span in a MnSOD-dependent manner, whereas inhibition of p38K cause
12 ochemistry for SIRT3 activity via acetylated MnSOD(K68) Murine AEC SIRT3 and cleaved caspase-9 (CC-9)
13 n cells that were pretreated with adenoviral MnSOD (AdMnSOD) plus 1,3-bis(2-chloroethyl)-1-nitrosoure
14       Transplantation of diabetic EPCs after MnSOD gene therapy restored their ability to mediate ang
15        Silencing studies using siRNA against MnSOD showed that similar results were observed in MnSOD
16 t ER stress via Akt-dependent PrP(C) and Akt-MnSOD pathway.
17 ndings, LPS induced NF-kappaB activation and MnSOD expression in isolated fetal pulmonary arterial en
18 these residues abrogates MKK4 activation and MnSOD expression.
19 death through downregulation of catalase and MnSOD.
20 iated with upregulation of eNOS, p-eNOS, and MnSOD, which reduce oxidative stress and have anti-infla
21 ing regulation of SIRT1/FoxO3a, MEK/ERK, and MnSOD, resulting in oxidative stress intolerance, thereb
22 ndicate that alterations of nitric oxide and MnSOD contribute to pathological HIF-1alpha expression a
23 e mitochondria contain fidelity proteins and MnSOD constitutes an integral part of the nucleoid compl
24 , were not statistically different in WT and MnSOD-Tg diabetic mice.
25                                           As MnSOD has been shown to remove superoxide radical with v
26 g expression of ROS scavenger genes, such as MnSOD, catalase and PRDX3.
27 repression of FOXO3a-regulated genes such as MnSOD, p27Kip1, and BIM-1.
28 rotonation" pathway than human and bacterial MnSODs and suggested that this could result from small s
29  MnSODs surpass those of human and bacterial MnSODs, due to very low level of product inhibition.
30 cantly more product-inhibited than bacterial MnSODs at high concentrations of superoxide (O(2)(-)).
31 /-) mice demonstrates an interaction between MnSOD, p53 and Polgamma.
32 onse to NAC exposure was an increase in both MnSOD protein and activity.
33 which leads to AP-1 dissociation followed by MnSOD transcription.
34 e stress and increased antioxidant capacity (MnSOD, CuSOD and Catalase activity).
35  the levels of MnSOD protein did not change, MnSOD activity and mitochondrial respiration decreased i
36  as ScMnSOD > D. radiodurans MnSOD > E. coli MnSOD > human MnSOD.
37  efficiencies scaled as Drad MnSOD > E. coli MnSOD > human MnSOD.
38 ct inhibition was similar to that in E. coli MnSOD, specifically a decrease in the rate constant for
39 ared to those of wild-type human and E. coli MnSOD.
40 roduct inhibition resembling that of E. coli MnSOD.
41 rt the crystal structure of Escherichia coli MnSOD with hydrogen peroxide cryotrapped in the active s
42 4 is different in human and Escherichia coli MnSOD.
43 with that of both human and Escherichia coli MnSODs was undertaken.
44 els of alphaA crystallin, betaB2 crystallin, MnSOD, and aconitase and decreased levels of ATP synthas
45 ion of alphaA crystallin, betaB2 crystallin, MnSOD, and Hsp70.
46 ine (K68Q), mimicking acetylation, decreased MnSOD activity in SNc dopaminergic neurons, whereas muta
47  to DMBA and TPA activated p53 and decreased MnSOD expression via p53-mediated suppression of Sp1 bin
48      Livers of Sirt3/ mice exhibit decreased MnSOD activity, but not immunoreactive protein, relative
49 RPE-J cells with Rz432 resulted in decreased MnSOD mRNA and protein as well as increased levels of su
50 diomyopathy may be attributable to decreased MnSOD expression.
51                     We found that decreasing MnSOD with small interfering RNA in MCF-7 cells resulted
52 wnregulating manganese superoxide dismutase (MnSOD) activity by causing the nitrosylation of tyrosine
53 ane-targeted 30 kDa Mn-superoxide dismutase (MnSOD) and a cytosolic FeSOD.
54 suggest that manganese superoxide dismutase (MnSOD) and calpain may be critical mediators of this pro
55 coding genes manganese superoxide dismutase (MnSOD) and catalase (Cat), thereby decreasing cellular l
56 eacetylating manganese superoxide dismutase (MnSOD) and mitochondrial 8-oxoguanine DNA glycosylase.
57 r 1177), and manganese superoxide dismutase (MnSOD) and reduced serum interleukin (IL)-6 with concomi
58 catalase and manganese superoxide dismutase (MnSOD) antioxidant genes and stimulate their transcripti
59 , increasing manganese superoxide dismutase (MnSOD) can increase intracellular H(2)O(2).
60 idant enzyme manganese superoxide dismutase (MnSOD) exacerbated amyloid pathology.
61    Manganese-dependent superoxide dismutase (MnSOD) expression also increased significantly in respon
62 ad increased manganese superoxide dismutase (MnSOD) expression, a manifestation of mitochondrial dysf
63 ncreased mitochondrial superoxide dismutase (MnSOD) expression, decreased DNA oxidation, reduced REV1
64              Manganese superoxide dismutase (MnSOD) from different species differs in its efficiency
65  Trx induces manganese superoxide dismutase (MnSOD) gene transcription by activating MKK4 via redox c
66 ffect on the manganese superoxide dismutase (MnSOD) gene was investigated.
67 xpression of manganese superoxide dismutase (MnSOD) in EPCs contributes to impaired would healing in
68 xpression of manganese superoxide dismutase (MnSOD) in IPAH-ECs paralleled increased HIF-1alpha level
69  target gene manganese superoxide dismutase (MnSOD) in the pulmonary endothelium.
70        Human manganese superoxide dismutase (MnSOD) is a homotetramer of 22 kDa subunits, a dimer of
71              Manganese superoxide dismutase (MnSOD) is a mitochondrially localized primary antioxidan
72              Manganese superoxide dismutase (MnSOD) is a nuclear encoded and mitochondrial matrix-loc
73        Human manganese superoxide dismutase (MnSOD) is characterized by a product inhibition stronger
74  subunits in manganese superoxide dismutase (MnSOD) is currently under scrutiny.
75 idant enzyme manganese superoxide dismutase (MnSOD) modulates the cellular redox environment by conve
76 ion of human manganese superoxide dismutase (MnSOD) mRNA in human lung carcinoma cells, A549, mediate
77 icotiana mitochondrial superoxide dismutase (MnSOD) or an Escherichia coli glutathione reductase (gor
78 NA levels of manganese superoxide dismutase (MnSOD) or glutamate cysteine ligase (GCL) expression.
79              Manganese superoxide dismutase (MnSOD) plays a critical role in the survival of aerobic
80  whether mitochondrial superoxide dismutase (MnSOD) provides protection.
81 othesis that manganese superoxide dismutase (MnSOD) regulates cellular redox flux and glucose consump
82 ctive enzyme manganese superoxide dismutase (MnSOD) was expressed in RPE-J cells, and adeno-associate
83 xpression of manganese superoxide dismutase (MnSOD) was reduced by 38%, indicating that the susceptib
84  lacking mitochondrial superoxide dismutase (MnSOD) were modestly drug-resistant, and elimination of
85              Manganese superoxide dismutase (MnSOD), a mitochondrial antioxidant enzyme, is necessary
86 ssion of mitochondrial superoxide dismutase (MnSOD), and the consequent inhibition of ROS formation a
87 idant enzyme manganese superoxide dismutase (MnSOD), as a RelA target and potential antinecroptotic g
88  [i.e., p65, manganese superoxide dismutase (MnSOD), phosphorylated extracellular signal-regulated ki
89 e levels, of manganese superoxide dismutase (MnSOD), the mitochondrial enzyme that catalyzes superoxi
90 xpression of manganese superoxide dismutase (MnSOD), when combined with certain chemicals that inhibi
91  deletion of manganese superoxide dismutase (MnSOD).
92 motetrameric manganese superoxide dismutase (MnSOD).
93 a manganese-containing superoxide dismutase (MnSOD).
94 27(kip1) and manganese superoxide dismutase (MnSOD).
95 S scavenging enzyme Mn-superoxide dismutase (MnSOD).
96  activity of manganese superoxide dismutase (MnSOD).
97 ging protein manganese superoxide dismutase (MnSOD); the alpha(1)-AR-p66Shc-dependent pathway involvi
98 nt defenses [manganese superoxide dismutase (MnSOD)P< 0.05; copper/zinc superoxide dismutaseP< 0.05;
99              Manganese superoxide dismutase (MnSOD/SOD2) is a mitochondria-resident enzyme that gover
100              Manganese superoxide-dismutase (MnSOD), copper-zinc superoxide dismutase (CuZnSOD), and
101 d-type (WT) manganese superoxide dismutases (MnSODs) from Saccharomyces cerevisiae and Candida albica
102  the dismutation efficiencies scaled as Drad MnSOD > E. coli MnSOD > human MnSOD.
103                                Further, Drad MnSOD is most effective at high superoxide fluxes found
104 ts cellular origin, a comparison of the Drad MnSOD efficiency with that of both human and Escherichia
105  X-ray crystal structures of E162D and E162A MnSOD reveal no significant structural changes compared
106 drogen bond interaction with His163 in E162A MnSOD.
107                         In the case of E162D MnSOD, an intervening solvent molecule fills the void cr
108                                    Elevating MnSOD levels in cells enhances the conversion of superox
109 e methylation of Sod2, the gene that encodes MnSOD, in the development of diabetic retinopathy and in
110 ng the longer transcript enhanced endogenous MnSOD mRNA levels, which was associated with an increase
111 na in diabetes, and their scavenging enzyme, MnSOD, becomes subnormal.
112 whether it is a feature common to eukaryotic MnSODs, we purified MnSOD from Saccharomyces cerevisiae
113 d approximately 5% decrease, males/females), MnSOD ( approximately 16% decrease, males only), cytochr
114  of this study suggest a protective role for MnSOD in retinal capillary cell death and, ultimately, i
115 pathology, strongly implicating the role for MnSOD in the pathogenesis of retinopathy in diabetes.
116 ease the expression of the FOXO target genes MnSOD and catalase.
117 eactive oxygen species (ROS)-reducing genes (MnSOD, catalase).
118 redox and signal transduction related genes, MnSOD, CuZnSOD, Nrf2, Keap1, GPx4 and Catalase was also
119      However, it is not known whether or how MnSOD participates in the mitochondrial repair processes
120                                        Human MnSOD exhibits a substantially higher level of product i
121                                        Human MnSOD has two poly(A) sites resulting in two transcripts
122                                        Human MnSOD is significantly more product-inhibited than bacte
123 gin of product inhibition by comparing human MnSOD with ScMnSOD.
124 D. radiodurans MnSOD > E. coli MnSOD > human MnSOD.
125 scaled as Drad MnSOD > E. coli MnSOD > human MnSOD.
126               Glu162 in homotetrameric human MnSOD spans a dimeric interface and forms a hydrogen bon
127  Glu162 at the tetrameric interface in human MnSOD supports stability and efficient catalysis and has
128 t MnSODs indicate the unique nature of human MnSOD in that it predominantly undergoes the inhibited p
129 erties of two site-specific mutants of human MnSOD in which Glu162 is replaced with Asp (E162D) and A
130 ase reporter gene under the control of human MnSOD promoter-enhancer elements and investigated the ch
131  prepared two site-specific mutants of human MnSOD with replacements of Phe66 with Ala and Leu (F66A
132 f Phe66 to Leu resulted in a mutant of human MnSOD with weakened product inhibition resembling that o
133 J-1 causes decreased expression of the human MnSOD.
134  are more similar to bacterial than to human MnSOD.
135                         The results identify MnSOD as a p53-regulated gene that switches between earl
136 D wild-type fibroblasts, which was absent in MnSOD homozygous knockout fibroblasts.
137 ice, the numbers of acellular capillaries in MnSOD-Tg nondiabetic and diabetic mice were similar to t
138 nsumption and percentage of S-phase cells in MnSOD wild-type fibroblasts, which was absent in MnSOD h
139 se and oxygen consumption, and a decrease in MnSOD activity.
140    NAC-induced G(1) arrest is exacerbated in MnSOD heterozygous fibroblasts.
141 , increased MnSOD activity when expressed in MnSOD/ MEFs, suggesting acetylation directly regulates f
142 evention of the exercise-induced increase in MnSOD activity via antisense oligonucleotides greatly at
143     MnSOD lines had a three-fold increase in MnSOD activity, but interestingly a five to nine-fold in
144 peroxide anion generation and an increase in MnSOD compared with untreated CNV eyes.
145 ls, which was associated with an increase in MnSOD protein levels and a decrease in the percentage of
146 of age, there was a 2- to 3-fold increase in MnSOD protein levels in Tg19959-MnSOD mice compared to T
147 hesized that an exercise-induced increase in MnSOD would provide cardioprotection by attenuating IR-i
148 igate the mechanism of product inhibition in MnSOD, two yeast MnSODs, one from Saccharomyces cerevisi
149 1/FoxO3a and MEK/ERK pathway are involved in MnSOD regulation by AC5.
150 showed that similar results were observed in MnSOD knockdown HUVECs following Mn(2+) supplementation,
151 ctor Mef2, and predictably, perturbations in MnSOD modify p38K-dependent phenotypes.
152  small interfering RNA led to a reduction in MnSOD gene expression.
153 through IkappaBalpha degradation resulted in MnSOD upregulation and preserved cell growth, whereas NF
154        However, despite extensive studies in MnSOD regulation and its role in cancer, when and how th
155 mitochondrial protein acetylation, including MnSOD(K68) SIRT3 enforced expression reduced oxidant-ind
156 s lung alveolar type II cells have increased MnSOD(K68) acetylation compared with controls.
157 porphyrin, mimicked the effects of increased MnSOD expression.
158 acetylation (lenti-MnSOD(K122-R)), increased MnSOD activity when expressed in MnSOD/ MEFs, suggesting
159  reducing oxidative stress through increased MnSOD.
160        However, a low level of p53 increases MnSOD gene transcription in the presence of the intronic
161 sing cyclin D1 protein levels and increasing MnSOD activity.
162 trated that p53 can both suppress and induce MnSOD expression depending on the balance of promoter an
163             Finally, IR was unable to induce MnSOD deacetylation or activity in Sirt3/ livers, and th
164 dependent transcriptional pathways to induce MnSOD expression.
165           Our data indicate that TPA-induced MnSOD expression was independent of p53 and most likely
166 and NOXO1 in A549 cells impaired TPA-induced MnSOD expression.
167  (FOXO) 3a led to a reduction in TPA-induced MnSOD gene expression.
168 demonstrate that UVB-induced mtDNA damage is MnSOD dependent.
169                         Introduction of K68R MnSOD rescued mitochondrial redox status and membrane po
170 Together, these results show that NF-kappaB, MnSOD, 14-3-3zeta, and cyclin B1 contribute to LDIR-indu
171 rential increase in the levels of the 1.5-kb MnSOD transcript was observed in quiescent cells, wherea
172 tion increases the mRNA levels of the 1.5-kb MnSOD transcript, which was consistent with a significan
173  an arginine, mimicking deacetylation (lenti-MnSOD(K122-R)), increased MnSOD activity when expressed
174 hermore, infection of Sirt3/ MEFs with lenti-MnSOD(K122-R) inhibited in vitro immortalization by an o
175 that are present in the 3'-UTR of the longer MnSOD transcript.
176 esults uncover a muscle-restricted p38K-Mef2-MnSOD signaling module that influences life span and str
177  in Drosophila, a p38 MAP kinase (p38K)/Mef2/MnSOD pathway is a coregulator of stress and life span.
178 mimicked by overexpressing the mitochondrial MnSOD (SOD2), whereas SOD2 depletion with small interfer
179 8K modulates expression of the mitochondrial MnSOD enzyme through the transcription factor Mef2, and
180  the oxidative addition of superoxide to Mn2+MnSOD leading to the formation of the peroxide-inhibited
181 ere determined in mice overexpressing MnSOD (MnSOD-Tg).
182                                   While most MnSODs rest as the oxidized form, ScMnSOD was isolated i
183 ent with small interfering RNA against mouse MnSOD was shown to inhibit the development of LDIR-induc
184 (iron, manganese [Mn], copper/zinc, nickel), MnSOD is the dominant form in the diatom Thalassiosira p
185 cells is mediated by ROS and ICAM-1, but not MnSOD.
186                   Lastly, K68 acetylation of MnSOD was significantly increased in the SNc of PD patie
187 hibited decreased expression and activity of MnSOD.
188 le in cancer, when and how the alteration of MnSOD expression occurs during the process of tumor deve
189 ings, clinical and epidemiologic analyses of MnSOD expression and AMPK activation indicated that the
190 cer elements and investigated the changes of MnSOD transcription using the 7,12-dimethylbenz(alpha)an
191 between the positive and negative control of MnSOD expression.
192                 To investigate the effect of MnSOD, retinal mitochondrial oxidative stress and electr
193                                 Elevation of MnSOD was eliminated by both sirtuin and MEK inhibitors,
194  modestly drug-resistant, and elimination of MnSOD in the phb-2, har-1, and spg-7 mutants enhanced re
195 3 to verify their roles in the expression of MnSOD at each stage of cancer development.
196                        Because expression of MnSOD protects against cell death, our findings reveal a
197 nt study showed that increased expression of MnSOD sensitized WEHI7.2 cells to glucocorticoid-induced
198 D-0354 suppressed LDIR-induced expression of MnSOD, 14-3-3zeta, and cyclin B1 and diminished the adap
199 s tolerance offered by the cytosolic form of MnSOD has possibly resulted in retention of only the cyt
200  and the release of cytosolic 24 kDa form of MnSOD was obligatory for developing oxidative stress tol
201 pressing either different molecular forms of MnSOD or MnSOD defective in the cleavage of signal/linke
202    Individual contribution of these forms of MnSOD to total oxidative stress tolerance was analysed u
203 between human and certain bacterial forms of MnSOD.
204 ger than that observed in bacterial forms of MnSOD.
205 e ICAM-1 expression and ROS independently of MnSOD, leading to a decrease in monocyte adhesion to end
206 ys a role in cytokine-dependent induction of MnSOD, IL-6, and FH, we assessed the effect of E1A on NF
207 odels, lentiviral shRNA-induced knockdown of MnSOD caused tumors that grew in the presence of TAM to
208      Conversely, siRNA-mediated knockdown of MnSOD in normal EPCs reduced their activity in diabetic
209  and small interfering (SI) RNA knockdown of MnSOD, but not of the copper-zinc SOD, increased HIF-1 p
210                       Although the levels of MnSOD protein did not change, MnSOD activity and mitocho
211 cate that lysine and arginine methylation of MnSOD during quiescence would allow greater accessibilit
212                 Site-directed mutagenesis of MnSOD lysine 122 to an arginine, mimicking deacetylation
213  our group have shown that overexpression of MnSOD in MCF-7 cells alters stabilization of HIF-1 alpha
214                            Overexpression of MnSOD inhibited diabetes-induced increases in mitochondr
215                            Overexpression of MnSOD inhibited IFN-gamma-mediated ROS accumulation and
216 myopathy was suppressed by overexpression of MnSOD, whereas protection afforded by the AC5 knockout (
217 trometry results showed a complex pattern of MnSOD-methylation at both lysine (68, 89, 122, and 202)
218 tage of membrane-targeting and processing of MnSOD in either bacteria or plants.
219                 c-jun-mediated repression of MnSOD and catalase occurred via mitochondrial complex I
220 he suppression and subsequent restoration of MnSOD expression were mediated by two transcription-fact
221 serving the visible absorbance of species of MnSOD and under catalytic conditions observing the absor
222 2 and His163 contributes to the stability of MnSOD, with the major unfolding transition occurring at
223 f peroxide in the product-inhibited state of MnSOD.
224 th in MCF7-BK-TR cells due to stimulation of MnSOD activity through agonistic effects at mitochondria
225 34, based upon structure-function studies of MnSOD enzymes with mutations at this site.
226  effect of p65 and led to the suppression of MnSOD gene transcription.
227                                 Targeting of MnSOD to the membrane and subsequent cleavage to release
228 how that MnSOD deficiency in skin tissues of MnSOD-heterozygous knockout (Sod2(+/-)) mice leads to in
229               We conclude that the 3'-UTR of MnSOD regulates MnSOD expression in response to differen
230 gates if the 3'-untranslated region (UTR) of MnSOD regulates its expression during transitions betwee
231 5 can overcome the negative effect of p53 on MnSOD expression.
232 ent with the bi-directional effect of p53 on MnSOD expression.
233 ce RNA reduces the positive effect of p53 on MnSOD gene transcription.
234 in antioxidant protection afforded by GCL or MnSOD.
235 either different molecular forms of MnSOD or MnSOD defective in the cleavage of signal/linker peptide
236 ntly in the reduced state (unlike most other MnSODs).
237 lexes were determined in mice overexpressing MnSOD (MnSOD-Tg).
238 -induced superoxide production and preserved MnSOD expression in vivo.
239                                   We propose MnSOD as a new molecular player contributing to the Warb
240 echanisms: induction of antioxidant proteins MnSOD and Nrf1, possibly via stimulation of PGC1alpha, a
241 ure common to eukaryotic MnSODs, we purified MnSOD from Saccharomyces cerevisiae (ScMnSOD).
242 nhibition scales as ScMnSOD > D. radiodurans MnSOD > E. coli MnSOD > human MnSOD.
243 scherichia coli and Deinococcus radiodurans) MnSODs.
244         When delivered by AAV, Rz432 reduced MnSOD protein and increased markers of oxidative damage,
245  conclude that the 3'-UTR of MnSOD regulates MnSOD expression in response to different growth states
246 Sirt3/ MEFs deacetylated lysine and restored MnSOD activity.
247                                  Restricting MnSOD expression or inhibiting AMPK suppresses the metab
248                               Thus, a single MnSOD caters to the reduction of superoxide radical in b
249 f a previously undiscovered plastid-specific MnSOD whose identity we validated immunochemically.
250 etylation of mitochondrial Sirt3 substrates, MnSOD and oligomycin-sensitivity conferring protein (OSC
251  increase while high concentrations suppress MnSOD expression.
252                                      Tg19959-MnSOD mice also had a 50% increase in catalase protein l
253 were restored to wild-type levels in Tg19959-MnSOD littermates.
254  increase in MnSOD protein levels in Tg19959-MnSOD mice compared to Tg19959 littermates.
255 le Abeta pools or Abeta oligomers in Tg19959-MnSOD mice compared to Tg19959 littermates.
256 ken together, these results demonstrate that MnSOD deletion in adipocytes triggered an adaptive stres
257 xposed to UVB radiation, we demonstrate that MnSOD has a critical role in preventing mtDNA damage by
258               The data also demonstrate that MnSOD has a role along with p53 to prevent mtDNA damage.
259                     Here we demonstrate that MnSOD upregulation in cancer cells establishes a steady
260  mitochondrial content in WAT and found that MnSOD deletion increased mitochondrial oxygen consumptio
261    These results support the hypothesis that MnSOD regulates a "metabolic switch" during progression
262          Here, we tested the hypothesis that MnSOD regulates the expression of HIF-1 alpha by modulat
263    Taken together, our results indicate that MnSOD serves as a biomarker of cancer progression and ac
264                           Here, we show that MnSOD deficiency in skin tissues of MnSOD-heterozygous k
265                        The results show that MnSOD expression was suppressed at a very early stage bu
266                In this study, we showed that MnSOD protein expression was elevated in response to TPA
267                   These results suggest that MnSOD provides cardioprotection by attenuating IR-induce
268  results demonstrate for the first time that MnSOD is a fidelity protein that maintains the activity
269                                          The MnSOD is post-translationally processed to 27 and 24 kDa
270 e, Tyr34, by phenylalanine (Y34F) causes the MnSOD from S. cerevisiae to react exclusively through th
271         Methylation-dependent changes in the MnSOD conformation and subsequent changes in the electro
272                        Overexpression of the MnSOD 3'-UTR representing the longer transcript enhanced
273 F-kappaB at the promoter and enhancer of the MnSOD gene in vivo were verified by the presence of the
274 gamma, which is prevented by addition of the MnSOD mimetic Mn(III)TE-2-PyP(5+).
275 ha (PGC-1alpha), in the transcription of the MnSOD.
276 ity of transformed cells indicating that the MnSOD/AMPK axis is critical to support cancer cell bioen
277 ssion and AMPK activation indicated that the MnSOD/AMPK pathway is most active in advanced stage and
278 3-mediated suppression of Sp1 binding to the MnSOD promoter in normal-appearing skin and benign papil
279 K4 activates NFkappaB for its binding to the MnSOD promoter, which leads to AP-1 dissociation followe
280 for the differences in the activities of the MnSODs that considers the release of peroxide as not alw
281  higher level of product inhibition than the MnSODs from bacteria.
282 f high concentrations of O(2)(-) among these MnSODs.
283                                        Tumor MnSOD and mitochondrial ERbeta are therefore targets for
284 E162A compared to 90 degrees C for wild-type MnSOD.
285 antly lower activity compared with wild-type MnSOD.
286 ha signaling is a major mechanism underlying MnSOD-dependent UCPs expression that consequently trigge
287                                        Using MnSOD-deficient mice we demonstrate that UVB-induced mtD
288 ptosis and undergo enzymatic elimination via MnSOD and CuZnSOD with further detoxification via catala
289 ll therapy using diabetic EPCs after ex vivo MnSOD gene transfer accelerates their ability to heal wo
290                                         When MnSOD is deficient, superoxide radical and its resulting
291                   We therefore asked whether MnSOD overexpression would prove beneficial against AD p
292 g the offspring of Tg19959 mice crossed with MnSOD-overexpressing mice.
293              Because WT and the mutant yeast MnSOD both rest in the 2+ state and become six-coordinat
294 e, is slightly further away from Mn in yeast MnSODs, which may result in their unusual resting state.
295 echanistically, the high efficiency of yeast MnSODs could be ascribed to putative translocation of an
296                         Our studies on yeast MnSODs indicate the unique nature of human MnSOD in that
297 ], the dismutation efficiencies of the yeast MnSODs surpass those of human and bacterial MnSODs, due
298 sm of product inhibition in MnSOD, two yeast MnSODs, one from Saccharomyces cerevisiae mitochondria (
299 tively function in the mechanism of WT yeast MnSODs.
300 sified by their catalytic metal as Cu/ZnSOD, MnSOD, or FeSOD.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top